Medtronic plc. vs Merck & Company, Inc. — Stock Comparison
Medtronic plc. (MDT) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Medtronic plc. scores ahead of Merck & Company, Inc. on Q·Score (7.4 vs 6.3 out of 10), led by Quality (6.7 vs 4.9) and Growth (7.9 vs 6.4). Merck & Company, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for MDT (+5.5%) than for MRK (-3.1%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consistently beats earnings estimates (4/4 quarters).
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MDT vs MRK: which stock scores better overall?
Based on Q·Score, Medtronic plc. (MDT) scores 7.4/10 versus Merck & Company, Inc. (MRK) at 6.3/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MDT or MRK?
Medtronic plc. (MDT) scores higher on Growth (7.9/10 vs 6.4/10). Medtronic plc. reports revenue growth (9.9% YoY) while Merck & Company, Inc. reports (5.1% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MDT or MRK more attractively valued?
Medtronic plc. (MDT) scores higher on Valuation (7.3/10 vs 6.5/10). MDT trades at 14.6× P/E versus MRK at 16.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MDT vs MRK?
There are 25 analysts covering MDT with a consensus price target of $98.44, and 26 analysts covering MRK with a consensus target of $147.77. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MDT or MRK?
Medtronic plc. (MDT) scores higher on Quality (6.7/10 vs 4.9/10). Net profit margin: MDT at 13.2%, MRK at 4.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MDT or MRK?
Medtronic plc. (MDT) scores higher on Financial Health (7.9/10 vs 7/10). Market beta: MDT at 0.57, MRK at 0.21. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MDT and MRK?
Medtronic plc. (MDT) has a market capitalisation of $119.5B, while Merck & Company, Inc. (MRK) has a market cap of $376.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MDT or MRK pay dividends?
MDT pays a dividend yield of 3.09%, while MRK pays a dividend yield of 2.23%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →